Asset Manager

Updated:

Eir Pharmaceuticals

Eir Pharmaceuticals is a asset manager based in Palo Alto; the Altss profile covers its classification, headquarters, registration, AUM band, and key contacts...

Eir Pharmaceuticals

EIR Pharmaceuticals is a pharmaceutical company founded in 2018 and headquartered in Olathe, Kansas.

General information

Firm type

Asset Manager

Location

Region

North America

Country

United States

City

Palo Alto

Corporate office

Palo Alto, CA, United States

Additional offices

Los Angeles, CA, United States · New York, NY, United States · Olathe, KS, United States · Santa Monica, CA, United States · Dallas, TX, United States

Frequently asked questions

Who runs Eir Pharmaceuticals?

No principals, executives, or board members are identified in any publicly available source for Eir Pharmaceuticals. Standard searches across corporate filings, press releases, and professional networks do not surface a named founder, CEO, or managing partner for this entity.

Where is Eir Pharmaceuticals headquartered, and where does it operate?

The entity lists a Palo Alto, California headquarters with additional offices in Los Angeles, New York, Olathe (Kansas), Santa Monica, and Dallas. This six-market footprint is unusual for a firm with no digital presence or disclosed operational activity.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on asset managers?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

More Palo Alto Asset Manager profiles